• Home
  • About Us
  • Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Medical And Healthcare Allied Healthcare International Inc. Reports Fiscal 2010 Third Quarter Results

Allied Healthcare International Inc. Reports Fiscal 2010 Third Quarter Results

Posted on August 3, 2010 Written by Annalyn Frame

SOURCE: Allied Healthcare International Inc.

Revenues Increased 7.9%, at Constant Exchange Rates; Operating Income Increased 15.8%, at Constant Exchange Rates & Excluding Acquisition Costs

NEW YORK, NY–(Marketwire – August 3, 2010) – Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI), a leading provider of flexible healthcare staffing
services in the United Kingdom, today issued financial results for its
fiscal 2010 third quarter ended June 30, 2010.

To provide investors with a better understanding of the Company’s
performance and because of fluctuations in foreign exchange rates, Allied
is discussing its revenue, gross profit, selling, general & administrative
(SG&A) expenses and operating income at constant exchange rates, which are
calculated using the comparable prior period weighted average exchange
rates. In addition, as the Company’s revenue and gross profit are
generated in the United Kingdom, an analysis, which is contained in the
Historical Revenue and Gross Profit table at the end of this press release,
is included of the last eleven quarters’ revenue and gross profit in pounds
sterling to enable investors to fully understand the underlying trends over
these periods without the effects of currency exchange rates.


Fiscal Third Quarter Results

                                    Three Months Ended
                                         June 30,
                                 ------------------------
                                                      %
                                   2010      2009   Change
                                 --------  -------- -----
                                         Revenue
                                 ------------------------

Homecare                         $ 59,270  $ 52,801  12.3%
Nursing Homes                       4,237     5,774 -26.6%
Hospitals                           4,551     4,528   0.5%
                                 --------  -------- -----
Total, at constant exchange
 rates                             68,058    63,103   7.9%
Effect of foreign exchange         (2,310)        -  -3.7%
                                 --------  -------- -----
Total, as reported               $ 65,748  $ 63,103   4.2%
                                 ========  ======== =====


                                        Three Months Ended June 30,
                                 -----------------------------------------
                                                                       %
                                   2010       %       2009     %     Change
                                 --------  -------  -------- ------  -----
                                               Gross Profit
                                 -----------------------------------------

Homecare                         $ 18,023     30.4% $ 16,272   30.8%  10.8%
Nursing Homes                       1,368     32.3%    1,843   31.9% -25.8%
Hospitals                           1,078     23.7%    1,058   23.4%   2.0%
                                 --------           --------         -----
Total, at constant exchange
 rates                             20,469     30.1%   19,173   30.4%   6.8%
Effect of foreign exchange           (701)                 -          -3.7%
                                 --------           --------         -----
Total, as reported               $ 19,768           $ 19,173           3.1%
                                 --------           --------         -----


                                                    SG&A
                                 -----------------------------------------
SG&A, at constant exchange rates
 & excluding acquisition costs   $ 17,114           $ 16,276           5.1%
Acquisition costs, at constant
 exchange rates                       595                  -           3.7%
                                 --------           --------         -----
SG&A, at constant exchange rates   17,709             16,276           8.8%
Effect of foreign exchange           (533)                 -          -3.3%
                                 --------           --------         -----
Total SG&A, as reported          $ 17,176           $ 16,276           5.5%
                                 --------           --------         -----


                                              Operating Income
                                 -----------------------------------------
Operating Income, at constant
 exchange rates & excluding
 acquisition costs               $  3,355           $  2,897          15.8%
Acquisition costs, at constant
 exchange rates                      (595)                 -         -20.5%
                                 --------           --------         -----
Operating Income, at constant
 exchange rates                     2,760              2,897          -4.7%
Effect of foreign exchange           (168)                 -          -5.8%
                                 --------           --------         -----
Operating Income, as reported    $  2,592           $  2,897         -10.5%
                                 ========           ========         =====


                                     Net income attributable to Allied
                                 -----------------------------------------
                                      Basic and            Basic and
                                     Diluted EPS          Diluted EPS
                                 -----------------------------------------
Net income attributable to
 Allied, excluding acquisition
 costs                           $ 2,270     $  0.05    $ 2,388    $  0.05
Acquisition costs                   (610)   -$  0.01          -          -
                                 -------     -------    -------    -------
Net income attributable to
 Allied                          $ 1,660     $  0.04    $ 2,388    $  0.05
                                 =======     =======    =======    =======

For the third quarter of fiscal 2010, total revenue increased 7.9%, to
$68.0 million, compared with $63.1 million reported during the same period
in fiscal 2009. Allied’s Homecare revenue grew 12.3% to $59.3 million. The
acquisition completed in this quarter contributed 4.0%, or $2.1 million, to
the increase in Homecare revenues. Nursing Homes revenue declined 26.6% to
$4.2 million and Hospitals revenue increased 0.5% to $4.5 million. After
the unfavorable impact of currency exchange of $2.3 million, revenue
increased 4.2% year over year to the reported $65.7 million.

Total gross profit for the third fiscal quarter increased 6.8% to $20.5
million, from $19.2 million for the comparable quarter in fiscal 2009.
Gross profit as a percentage of revenue was 30.1%, compared with 30.4% for
the comparable prior-year period. Foreign exchange decreased gross profit
by $0.7 million to the reported $19.8 million for the 2010 third fiscal
quarter.

SG&A, excluding acquisition costs, for the third fiscal quarter was $17.1
million (25.1% of revenues), an increase of 5.1%, from $16.3 million (25.8%
of revenues) reported last year. The Company also incurred acquisition
costs of $0.6 million. Foreign exchange decreased costs by $0.5 million to
the reported $17.2 million for the 2010 third fiscal quarter.

Operating income, before acquisition costs, for the third quarter of fiscal
2010 increased by 15.8% to $3.4 million from $2.9 million a year ago.
Acquisition costs decreased operating income by $0.6 million. Foreign
exchange decreased operating income by $0.2 million to the reported $2.6
million for the 2010 third fiscal quarter.

Income attributable to Allied, excluding acquisition costs, for the third
quarter of fiscal 2010 was $2.3 million, or $0.05 per diluted share. Net
income attributable to Allied for the third quarter of fiscal 2010 was $1.7
million, or $0.04 per diluted share, compared with $2.4 million, $0.05 per
diluted share, reported during the 2009 third fiscal quarter.


Fiscal Nine Months Results

                                 Nine Months Ended June 30,
                                 --------------------------
                                                       %
                                   2010      2009    Change
                                 --------- --------- ------
                                          Revenue
                                 --------------------------

Homecare                         $ 167,474 $ 145,497  15.1%
Nursing Homes                       13,471    19,295 -30.2%
Hospitals                           14,451    15,173  -4.8%
                                 --------- --------- ------
Total, at constant exchange
 rates                             195,396   179,965   8.6%
Effect of foreign exchange           5,266         -   2.9%
                                 --------- --------- ------
Total, as reported               $ 200,662 $ 179,965  11.5%
                                 ========= ========= ======


                                         Nine Months Ended June 30,
                                 -----------------------------------------
                                                                       %
                                   2010       %       2009     %    Change
                                 --------  -------  -------- ------  -----
                                               Gross Profit
                                 -----------------------------------------

Homecare                         $ 51,380     30.7% $ 45,283   31.1%  13.5%
Nursing Homes                       4,330     32.1%    6,027   31.2% -28.2%
Hospitals                           3,292     22.8%    3,842   25.3% -14.3%
                                 --------           --------         -----
Total, at constant exchange
 rates                             59,002     30.2%   55,152   30.6%   7.0%
Effect of foreign exchange          1,591                  -           2.9%
                                 --------           --------         -----
Total, as reported               $ 60,593           $ 55,152           9.9%
                                 --------           --------         -----


                                                    SG&A
                                 -----------------------------------------
SG&A, at constant exchange rates
 & excluding acquisition costs   $ 48,743           $ 46,224           5.4%
Acquisition costs, at constant
 exchange rates                       595                  -           1.3%
                                 --------           --------         -----
SG&A, at constant exchange rates   49,338             46,224           6.7%
Effect of foreign exchange          1,264                  -           2.8%
                                 --------           --------         -----
Total SG&A, as reported          $ 50,602           $ 46,224           9.5%
                                 --------           --------         -----


                                                Operating Income
                                 -----------------------------------------
Operating Income, at constant
 exchange rates & excluding
 acquisition costs               $ 10,259           $  8,928          14.9%
Acquisition costs, at constant
 exchange rates                      (595)                 -          -6.7%
                                 --------           --------         -----
Operating Income, at constant
 exchange rates                     9,664              8,928           8.2%
Effect of foreign exchange            327                  -           3.6%
                                 --------           --------         -----
Operating Income, as reported    $  9,991           $  8,928          11.9%
                                 ========           ========         =====


                                     Net income attributable to Allied
                                 -----------------------------------------
                                      Basic and            Basic and
                                     Diluted EPS          Diluted EPS
                                 -----------------------------------------
Income from continuing
 operations attributable to
 Allied, excluding acquisition
 costs                           $ 7,766     $  0.17    $ 6,999    $  0.15
Acquisition costs                   (610)   -$  0.01          -          -
                                 -------     -------    -------    -------
Net income attributable to
 Allied                          $ 7,156     $  0.16    $ 6,999    $  0.15
                                 =======     =======    =======    =======

For the nine months of fiscal 2010 total revenue increased 8.6%, to $195.4
million, compared with $180.0 million for the same period in fiscal 2009.
Allied’s Homecare revenue grew 15.1% to $167.5 million. The acquisition
completed in the third quarter of fiscal 2010 contributed 1.4%, or $2.1
million, to the increase in Homecare revenues. Nursing Homes revenue
declined 30.2% to $13.5 million and Hospitals revenue declined 4.8% to
$14.4 million. After the favorable impact of currency exchange of $5.3
million, revenue increased 11.5% year over year to the reported $200.7
million for the fiscal 2010 nine-month period.

Total gross profit for the nine months of fiscal 2010 increased 7.0% to
$59.0 million, from $55.2 million for the comparable period in fiscal 2009.
Gross profit as a percentage of revenue was 30.2%, compared with 30.6% for
the comparable prior-year period. Foreign exchange increased gross profit
by $1.6 million to the reported $60.6 million for the fiscal 2010
nine-month period.

SG&A, excluding acquisition costs, for the nine months of fiscal 2010 was
$48.7 million (24.9% of revenues), an increase of 5.4%, from $46.2 million
(25.7% of revenues) reported last year. We also incurred acquisition
costs of $0.6 million. Foreign exchange increased costs by $1.3 million to
the reported $50.6 million for the fiscal 2010 nine month period.

Operating income, before acquisition costs, for the nine months of fiscal
2010 increased by 14.9% to $10.3 million from $8.9 million a year ago.
Acquisition costs decreased operating income by $0.6 million. Foreign
exchange increased operating income by $0.3 million to the reported $10.0
million for the fiscal 2010 nine month period.

Income attributable to Allied, excluding acquisition costs, for the nine
months of fiscal 2010 was $7.8 million, or $0.17 per diluted share. Income
attributable to Allied for the nine months of fiscal 2010 was $7.2 million,
or $0.16 per diluted share, compared with $7.0 million, $0.15 per diluted
share, reported during the fiscal 2009 nine month period.

Cash balances as of June 30, 2010 were $37.0 million (£24.5 million) as
compared to $41.6 million (£27.6 million) as of March 31, 2010. The
decrease was primarily due to payments on acquisition and the Company’s
share buy back program.

For the fiscal nine months ended June 30, 2010, depreciation and
amortization was $3.2 million (£2.0 million), capital expenditures were
$2.4 million (£1.6 million). Days Sales Outstanding was 27 days at June 30,
2010 (42 days including unbilled account receivables), and 24 days at June
30, 2009 (46 days including unbilled account receivables).

Management Discussion

Sandy Young, Chief Executive Officer of Allied, commented, “Allied’s
Homecare revenue increased by 12.3% year over year. This is less than
previous growth levels and includes a 4.0% contribution from our newly
acquired Homecare business in Ireland. We are pleased with the transaction
progress and see opportunities to share our knowledge of Continuing Care
and learn from the Irish experience of supported living. We anticipate that
the contribution from our Irish business will exceed £10 million in revenue
and £1.2 million in EBITDA in the coming fiscal year. We believe the low
level of outsourcing in the Republic of Ireland will accelerate as the
government tries to extract the best value for taxpayers.

“There is no doubt that with the new budget year, which commenced in April,
Local Authorities have been controlling their spending. We have not seen
any significant decline so far, but local authority social care only
increased by 5.4%. In contrast, Continuing Care, which is funded by the
National Health Services (NHS) Primary Care Trusts (PCT’s), grew by 18%,
resulting in total growth in our Homecare business of 8.3% before the
benefits of Ireland.

“It has been reported that NHS spending will be protected over the life of
the parliament and we expect new outsourcing opportunities to emerge.
Although there will be a change from NHS Primary Care Trusts (about 150
nationally) to General Practitioner Consortia (about 500 nationally) within
two years, we do not see why that will restrict growth. At present PCT’s
outsource only a proportion of their spending and more care will be joint
commissioned as they try to bridge the gap between Healthcare and Social
Care. We are very well positioned to capitalize on these changes in the
industry.

“We have significant scope to increase our Continuing Care business as only
60 of our 113 total branches provide Continuing Care. Further, only about
12 branches provide the full range of Continuing Care, which includes high
intensity patients. We currently have plans to increase our sales and
marketing expenditures to promote these opportunities. We are also
exploring new service lines and during the quarter we piloted the Rapid
Intervention Service for End-of-life care (RISE) launched by NHS
Oxfordshire in July.

“The service aims to make first contact with a patient within 20 minutes at
times of crisis. The team operates between 8.00 am and 10.00 pm seven days
a week and can offer care and support for a maximum of six days. If
patients require overnight care, then the service will link with Marie
Curie Night Service or Out of Hours services. Furthermore, if ongoing care
is required, the RISE team also works to make sure other services are
involved so care can be continued if necessary.

“While we are positive about health spending, we can see there may be some
slowing in Local Authority spending. However, we believe that the larger
dynamics in this business will continue to have a positive impact.
Firstly, there is the steady increase because of the ageing profile of the
population. Secondly, a number of Local Authorities have not outsourced
care to the private sector. Thirdly, the reduction in the number of
suppliers used by each Authority will favor the larger players.

“Finally, quality is a major driver and we are delighted that we now have
91% of our branches rated by the Government (CQC) as good or excellent. In
the provision of such a sensitive service, quality is paramount.

“In the last month, we have won a 1,000 hours per week contract in Wales,
an 1,100 hour per week extra care scheme in London, and a place on the West
London Alliance which could be significantly more than 1,000 hours per
week.

“So we are still winning business but cannot quantify the effects of
savings in other areas. We are well placed to benefit from volume deals and
some of the smaller providers may find the temporary volume restrictions
hard.

“Overall I would hope that our Homecare business (before the benefit of
Ireland) can continue to grow in the 5% to 10% range rather than the 10% to
15% range previously highlighted. I think the 5% to 10% growth level will
be a feature of the medium term as the Local Authorities and PCT’s adjust,
but thereafter I see no reason why we will not return to the higher levels
of growth, particularly given the reinforced emphasis on outsourcing. There
are already other outsourcing opportunities Allied can initiate.

“Our Nursing Home activities continued to decline and we do not foresee any
immediate change. However, with Hospital Staffing we have posted a small
growth of 1%. We have also started to extract this business from our
Homecare network to allow for more focus. It now reports in to our
Commercial Director.”

Mr. Young concluded, “To support our commitment to providing our customers
with one of the highest levels of quality care in our industry and to
enhancing our leadership, Professor Raymond J. Playford has been appointed
to the new post of Medical Advisor to our Board. Professor Playford has
more than 25 years of experience in the medical field, specialising in
clinical research, and we look forward to benefiting from his profound
health care expertise, particularly in this environment.”

Dr. Jeff Peris, Chairman of Allied, commented, “Looking forward, we will
focus on executing our business strategy and building value for our
shareholders through organic growth, new service opportunities, strategic
acquisitions, as well as through our share buyback program. As of July 30,
2010 we had repurchased 1.1 million shares, or approximately $2.8 million,
of our stock under the $10 million stock repurchase program announced in
May 2010.”

Conference Call Information: August 3, 2010 at 10:00 AM Eastern Time /
3:00 PM UK Time

Allied will host a call and webcast today at 10:00 AM Eastern Time / 3:00
PM UK Time, to discuss its financial results. To join the call, please dial
(877) 407-8031 for domestic participants and (201) 689-8031 for
international participants. Participants may also access a live webcast of
the conference call through the “Investors” section of Allied Healthcare’s
Website: www.alliedhealthcare.com. A telephone replay will be available
until August 31st following the call by dialing (877) 660-6853 for domestic
participants and (201) 612-7415 for international participants. When
prompted, please enter account number 286 and conference ID number 353906.
A webcast replay will also be available and archived on the Company’s
website for ninety days.

Reconciliation of GAAP and Non-GAAP Data

In addition to disclosing results of operations that are determined in
accordance with generally accepted accounting principles (“GAAP”), this
press release also discloses non-GAAP results of operations that exclude or
include certain charges. These non-GAAP measures adjust for foreign
exchange effects and acquisition costs. Management believes that the
presentation of these non-GAAP measures provides useful information to
investors regarding the Company’s results of operations, as these non-GAAP
measures allow investors to better evaluate ongoing business performance.
Investors should consider non-GAAP measures in addition to, and not as a
substitute for, financial measures prepared in accordance with GAAP. A
reconciliation of the non-GAAP measures disclosed in this press release
with the most comparable GAAP measures are included in the financial tables
included in this press release.

ABOUT ALLIED HEALTHCARE INTERNATIONAL INC.

Allied Healthcare International Inc. is a leading provider of flexible
healthcare staffing services in the United Kingdom. Allied operates a
community-based network of approximately 115 branches with the capacity to
provide carers (known as home health aides in the U.S.), nurses, and
specialized medical personnel to locations covering approximately 90% of
the U.K. population. Allied meets the needs of private patients, community
care, nursing and care homes, and hospitals. For more news and information
please visit: www.alliedhealthcare.com.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release may be forward-looking
statements. These forward-looking statements are based on current
expectations and projections about future events. Actual results could
differ materially from those discussed in, or implied by, these
forward-looking statements. Factors that could cause actual results to
differ from those implied by the forward-looking statements include:
general economic and market conditions; the effect of the change in the
U.K. government and the impact of proposed changes in recent policy making
related to health and social care that may reduce revenue and
profitability; Allied’s ability to continue to recruit and retain flexible
healthcare staff; Allied’s ability to enter into contracts with local
government social services departments, NHS Trusts, hospitals, other
healthcare facility clients and private clients on terms attractive to
Allied; the general level of demand and spending for healthcare and social
care; dependence on the proper functioning of Allied’s information systems;
the effect of existing or future government regulation of the healthcare
and social care industry, and Allied’s ability to comply with these
regulations; the impact of medical malpractice and other claims asserted
against Allied; the effect of regulatory change that may apply to Allied
and that may increase costs and reduce revenues and profitability; Allied’s
ability to use net operating loss carry forwards to offset net income; the
effect that fluctuations in foreign currency exchange rates may have on our
dollar-denominated results of operations; and the impairment of goodwill,
of which Allied has a substantial amount on the balance sheet, may have the
effect of decreasing earnings or increasing losses. Other factors that
could cause actual results to differ from those implied by the
forward-looking statements in this press release include those described in
Allied’s most recently filed SEC documents, such as its most recent annual
report on Form 10-K, all quarterly reports on Form 10-Q and any current
reports on Form 8-K filed since the date of the last Form 10-K. Allied
undertakes no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events, or
otherwise.



ALLIED HEALTHCARE INTERNATIONAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

                                  Three Months Ended    Nine Months Ended
                                --------------------- --------------------
                                 June 30,   June 30,   June 30,   June 30,
                                   2010       2009       2010       2009
                                ---------  ---------- ---------  ---------
Revenues:
  Net patient services          $  65,748  $   63,103 $ 200,662  $ 179,965
                                ---------  ---------- ---------  ---------

Cost of revenues:
  Patient services                 45,980      43,930   140,069    124,813
                                ---------  ---------- ---------  ---------

     Gross profit                  19,768      19,173    60,593     55,152

Selling, general and
 administrative expenses           17,176      16,276    50,602     46,224
                                ---------  ---------- ---------  ---------

     Operating income               2,592       2,897     9,991      8,928

Interest income                        84          76       275        453
Interest expense                      (10)          -       (10)       (12)
Foreign exchange (loss) income        (46)        307      (259)       (60)
                                ---------  ---------- ---------  ---------

     Income before income
      taxes and discontinued
      operations                    2,620       3,280     9,997      9,309

Provision for income taxes            903         892     2,784      2,310
                                ---------  ---------- ---------  ---------

     Income from continuing
      operations                    1,717       2,388     7,213      6,999
                                ---------  ---------- ---------  ---------

Discontinued operations:
Income from discontinued
 operations, net of taxes               -           -         -        367
                                ---------  ---------- ---------  ---------

Net income                          1,717       2,388     7,213      7,366

Less: Net income attributable
 to noncontrolling interest           (57)          -       (57)         -
                                ---------  ---------- ---------  ---------

Net income attributable to
 Allied Healthcare
 International Inc.             $   1,660  $    2,388 $   7,156  $   7,366
                                =========  ========== =========  =========

Amounts attributable to Allied
 Healthcare International Inc.:
     Income from continuing
      operations, net of tax    $   1,660  $    2,388 $   7,156  $   6,999
     Discontinued operations,
      net of tax                        -           -         -        367
                                ---------  ---------- ---------  ---------
     Net income                 $   1,660  $    2,388 $   7,156  $   7,366
                                =========  ========== =========  =========

Earnings per share - basic and
 diluted attributable to Allied
 Healthcare International Inc.
 common shareholders
     Income from continuing
      operations                $    0.04  $     0.05 $    0.16  $    0.15
     Discontinued operations            -           -         -       0.01
                                ---------  ---------- ---------  ---------
Net income attributable to
 Allied Healthcare
 International Inc.
 common shareholders            $    0.04  $     0.05 $    0.16  $    0.16
                                =========  ========== =========  =========

Weighted average number of
 common shares outstanding:
     Basic                         45,045      44,986    45,102     44,986
                                =========  ========== =========  =========
     Diluted                       45,269      44,998    45,363     44,990
                                =========  ========== =========  =========





ALLIED HEALTHCARE INTERNATIONAL INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)

                                                    June 30,  September 30,
                                                      2010         2009
                                                  (Unaudited)
                                                  -----------  -----------
ASSETS

Current assets:
  Cash and cash equivalents                       $    36,954  $    35,273
  Accounts receivable, less allowance for
   doubtful accounts of $694 and $839,
   respectively                                        19,584       19,594
  Unbilled accounts receivable                         10,970       11,572
  Deferred income taxes                                   403          389
  Prepaid expenses and other assets                     1,501        1,188
                                                  -----------  -----------
         Total current assets                          69,412       68,016

Property and equipment, net                             9,303        7,756
Goodwill                                               98,114       95,649
Other intangible assets, net                            3,699        1,646
                                                  -----------  -----------
         Total assets                             $   180,528  $   173,067
                                                  ===========  ===========

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
  Accounts payable                                $     1,099  $     1,186
  Current maturities of debt and capital leases           567            -
  Accrued expenses, inclusive of payroll and
   related expenses                                    24,866       24,304
  Taxes payable                                           970          201
                                                  -----------  -----------
         Total current liabilities                     27,502       25,691

Long-term debt and capital leases,
 net of current maturities                                394            -
Deferred income taxes                                   1,425          103
Other long-term liabilities                               294            -
                                                  -----------  -----------
         Total liabilities                             29,615       25,794
                                                  -----------  -----------

Commitments and contingencies

                                                  -----------  -----------
Noncontrolling interest                                 4,028            -
                                                  -----------  -----------

Shareholders' equity:
  Preferred stock, $.01 par value; authorized
   10,000 shares, issued and outstanding - none             -            -
  Common stock, $.01 par value; authorized 80,000
   shares, issued 45,721 and 45,571 shares,
   respectively                                           457          456
  Additional paid-in capital                          242,312      241,555
  Accumulated other comprehensive loss                (21,403)     (14,418)
  Accumulated deficit                                 (70,870)     (78,026)
                                                  -----------  -----------
                                                      150,496      149,567
  Less cost of treasury stock (1,089 and 585
   shares, respectively)                               (3,611)      (2,294)
                                                  -----------  -----------
         Total shareholders' equity                   146,885      147,273
                                                  -----------  -----------
         Total liabilities and shareholders'
          equity                                  $   180,528  $   173,067
                                                  ===========  ===========





ALLIED HEALTHCARE INTERNATIONAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

                                                        Nine Months Ended
                                                        June 30,  June 30,
                                                          2010      2009
                                                        --------  --------
Cash flows from operating activities:
  Net income                                            $  7,213  $  7,366
  Adjustments to reconcile net income to net
   cash provided by operating activities:
     Income from discontinued operations                       -      (367)
     Depreciation and amortization                         2,242     1,880
     Amortization of intangible assets                       952       921
     Foreign exchange gain                                    (2)     (221)
     (Decrease) increase in provision for
      allowance for doubtful accounts                        (24)      100
     (Gain) loss on sale of fixed assets                      (2)       11
     Stock based compensation                                471       366
     Deferred income taxes                                   102      (246)
  Changes in operating assets and liabilities,
   excluding the effect of businesses acquired and
   sold:
     Increase in accounts receivable                        (335)     (518)
     Decrease (increase) in prepaid expenses
      and other assets                                       671    (1,137)
     Increase in accounts payable and other
      liabilities                                          1,693     2,875
                                                        --------  --------

        Net cash provided by continuing
         operations                                       12,981    11,030
                                                        --------  --------

Cash flows from investing activities:
  Capital expenditures                                    (2,428)   (2,152)
  Proceeds from sale of business                               -       114
  Proceeds from sale of property and equipment                62         1
  Acquisition of controlling interest,
   net of cash acquired                                   (5,812)        -
  Payments on acquisitions payable                             -      (171)
                                                        --------  --------

        Net cash used in investing activities             (8,178)   (2,208)
                                                        --------  --------

Cash flows from financing activities:
  Stock options exercised                                    288         -
  Borrowings under invoice discounting facility, net         248         -
  Repayments of debt and capital lease obligations          (121)        -
  Treasury shares acquired                                (1,317)        -
                                                        --------  --------

        Net cash used in financing activities               (902)        -
                                                        --------  --------

Effect of exchange rate on cash                           (2,220)   (1,361)
                                                        --------  --------

Increase in cash                                           1,681     7,461

Cash and cash equivalents, beginning of period            35,273    26,199
                                                        --------  --------

Cash and cash equivalents, end of period                $ 36,954  $ 33,660
                                                        ========  ========

Supplemental cash flow information:
  Cash paid for interest                                $     10  $    300
                                                        ========  ========

  Cash paid for income taxes, net                       $  1,025  $    137
                                                        ========  ========

Supplemental disclosure of non-cash investing
 and financing activities:
  Capital expenditures included in accrued expenses
   and other long-term liabilities                      $    609  $      -
                                                        ========  ========

  Details of business acquired in purchase
   transactions:
     Fair value of assets acquired                      $ 12,430
                                                        ========

     Liabilities assumed or incurred                    $  2,694
                                                        ========

     Noncontrolling interest                            $  3,888
                                                        ========

     Cash paid for acquisitions                         $  5,848
     Cash acquired                                            36
                                                        --------

     Net cash paid for acquisitions                     $  5,812
                                                        ========





ALLIED HEALTHCARE INTERNATIONAL INC.
HISTORICAL REVENUE AND GROSS PROFIT
(In thousands, except foreign exchange rate)
(Unaudited)

                                             Revenue
                                ---------- ---------- ----------
                                    Q3         Q2         Q1
                                  2010       2010       2010
                                ---------- ---------- ----------

Homecare                        GBP 38,323 GBP 35,860 GBP 35,903
Nursing Homes                        2,731      2,864      3,261
Hospitals                            2,933      3,235      3,330
                                ---------- ---------- ----------
Total                           GBP 43,987 GBP 41,959 GBP 42,494
Foreign Exchange rate                 1.49       1.56       1.63
                                ---------- ---------- ----------
                                $   65,748 $   65,530 $   69,384
                                ========== ========== ==========


                                                 Revenue
                                ---------- ---------- ---------- ----------
                                    Q4         Q3         Q2         Q1
                                  2009       2009       2009       2009
                                ---------- ---------- ---------- ----------

Homecare                        GBP 35,763 GBP 34,162 GBP 30,858 GBP 30,620
Nursing Homes                        3,986      3,716      4,159      4,808
Hospitals                            2,956      2,914      3,448      3,612
                                ---------- ---------- ---------- ----------
Total                           GBP 42,705 GBP 40,792 GBP 38,465 GBP 39,040
Foreign Exchange rate                 1.64       1.55       1.44       1.58
                                ---------- ---------- ---------- ----------
                                $   69,845 $   63,103 $   55,334 $   61,528
                                ========== ========== ========== ==========


                                                 Revenue
                                ---------- ---------- ---------- ----------
                                    Q4         Q3         Q2         Q1
                                  2008       2008       2008       2008
                                ---------- ---------- ---------- ----------

Homecare                        GBP 30,218 GBP 29,130 GBP 27,561 GBP 27,358
Nursing Homes                        5,140      4,969      5,373      5,730
Hospitals                            4,088      3,926      4,358      3,473
                                ---------- ---------- ---------- ----------
Total                           GBP 39,446 GBP 38,025 GBP 37,292 GBP 36,561
Foreign Exchange rate                 1.90       1.97       1.98       2.05
                                ---------- ---------- ---------- ----------
                                $   74,968 $   75,024 $   73,815 $   74,770
                                ========== ========== ========== ==========



                                          Gross Profit
                                ---------- ---------- ----------
                                    Q3         Q2         Q1
                                  2010       2010       2010
                                ---------- ---------- ----------

Homecare                        GBP 11,651 GBP 11,083 GBP 11,041
Nursing Homes                          882        931      1,033
Hospitals                              696        755        712
                                ---------- ---------- ----------
Total                           GBP 13,229 GBP 12,769 GBP 12,786
Foreign Exchange rate                 1.49       1.56       1.63
                                ---------- ---------- ----------
                                $   19,768 $   19,948 $   20,877
                                ========== ========== ==========


                                               Gross Profit
                                ---------- ---------- ---------- ----------
                                    Q4         Q3         Q2         Q1
                                  2009       2009       2009       2009
                                ---------- ---------- ---------- ----------

Homecare                        GBP 10,951 GBP 10,525  GBP 9,753  GBP 9,487
Nursing Homes                        1,257      1,187      1,298      1,477
Hospitals                              745        679        874        973
                                ---------- ---------- ---------- ----------
Total                           GBP 12,953 GBP 12,391 GBP 11,925 GBP 11,937
Foreign Exchange rate                 1.64       1.55       1.44       1.58
                                ---------- ---------- ---------- ----------
                                $   21,196 $   19,173 $   17,166 $   18,813
                                ========== ========== ========== ==========


                                               Gross Profit
                                ---------- ---------- ---------- ----------
                                    Q4         Q3         Q2         Q1
                                  2008       2008       2008       2008
                                ---------- ---------- ---------- ----------

Homecare                         GBP 9,447  GBP 9,294  GBP 8,476  GBP 8,491
Nursing Homes                        1,554      1,531      1,596      1,706
Hospitals                            1,050        888      1,009        767
                                ---------- ---------- ---------- ----------
Total                           GBP 12,051 GBP 11,713 GBP 11,081 GBP 10,964
Foreign Exchange rate                 1.90       1.97       1.98       2.05
                                ---------- ---------- ---------- ----------
                                $   22,911 $   23,120 $   21,931 $   22,423
                                ========== ========== ========== ==========

Contact:

Allied Healthcare International Inc.
Sandy Young
Chief Executive Officer
Paul Weston
Chief Financial Officer
+44 (0) 17 8581 0600
Or
Piper Jaffray Ltd. (Nominated Adviser)
Matthew Flower
Rupert Winckler
+44 (0) 20 3142 8700
Or
ICR, LLC
Sherry Bertner
Managing Director
+1 646 277 1200
[email protected]

Filed Under: Medical And Healthcare

Recent News

  • Study Reveals Most Kids Hospitalized for Allergic Reactions Could Be Home in Two Hours June 10, 2025
  • Fidelis Care Launches Major Grant Push to Fix Gaps in Postpartum Mental Health Care June 10, 2025
  • DarioHealth Strikes Gold with Major Health Plan Deal, Boosting Revenue and Market Position March 18, 2025
  • Texas Patients Left in the Dark? This Bill Aims to Change That March 17, 2025
  • Health Insurance Denied Your Claim? This Company is Stepping In to Pay for Your Care March 6, 2025
  • Big Changes in Atlanta—Peach State Health Plan Invests in a Major Housing Overhaul March 6, 2025
  • Wellmark Joins Forces with Evio Pharmacy to Make Medications More Affordable March 6, 2025
  • Raintree Systems Snaps Up Yoomi Health in a Bold AI Move for Rehab Therapy January 24, 2025
  • Medicare’s New $2,000 Cap: How Enrollees Will Save Thousands in 2025 January 16, 2025
  • Breaking Barriers: How ‘Ohana Health Plan is Reshaping Care for Hawaii’s Most Vulnerable January 16, 2025

Search Our Site

Categories

  • AARP
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • Humana
  • MedBasics
  • Medical And Healthcare
  • Medical Malpractice
  • Medicare
  • Senior News
  • The SCOOTER Store

Our Partners

Portal of Dallas
Auto News Review
OSS News Review
Holly Bushes
Rose Bushes
SatelliteDish.Net
I Go Cars
Bad School Photos
Canonical Tag
Check A Domain
Idaho Resorts
iWannaBeFamous
Mabank Online
Stockyards
TravelXL

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Achieve Your Weight Goals with Advanced Thermogenic with NMN
  • Affordable Health Insurance
  • Anavar: A Deep Dive into Athletic Benefits, Potential Side Effects, and Weight Loss Applications
    • Anavar Cycle: Benefits, Dosages, and Side Effects
      • Anavar Cycle: Benefits, Dosages, and Side Effects
    • Deca Durabolin vs Anavar: Comparing Performance Enhancers
  • B12 Elite Elixir: Vitalizing Your Health and Energy Levels
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Disclaimer
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Elite Health Online Dual Stack approach: Unlock your weight loss potential
  • Elite Thermogenic Formula: A Game-Changer in Weight Management and Metabolic Health
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Harnessing the Power of HGH for Vitality and Youthfulness
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
    • Harmonizing Body and Spirit: Navigating through Hormone Replacement Therapy
    • Hormone Replacement Therapy (HRT) – A Double-Edged Sword
    • Hormone Replacement Therapy (HRT): A Guide to Rebalancing Hormones
    • Hormone Replacement Therapy (HRT): Balancing the Benefits, Side Effects, and Menopausal Relief
    • Hormone Replacement Therapy: Benefits & Considerations
  • Hot ROCS: The Ultimate Solution for Enhanced Energy and Metabolism
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Device CROs: The Role in Research and Development
  • Medical Malpractice
  • Medical Research Consultants
  • Menopause and HRT
  • Mounjaro (Tirzepatide): A Breakthrough in Diabetes and Obesity Management
  • Nicotinamide Adenine Dinucleotide – Unleashing Vital Molecule Power for Optimal health
    • Unlocking the Power of NMN in Our Advanced Thermogenic and NMN Formula
  • Oxytocin Benefits
    • Oxytocin: The Love Hormone Decoded
    • Oxytocin: The Love Hormone’s Role in Bonding and Beyond
  • Oxytocin Benefits and Hormone Therapy
  • Peptides: The Future of Health and Wellness
    • Semax Peptide – A Glimpse into Nootropic Advancements
  • Personal Lubricants for Women – Liven Up Your Life!
  • Phentermine: Benefits, Usage, and Potential Side Effects
  • Privacy Policy
  • Private Health Insurance Plans
  • Rapamycin, the anti-aging marvel and its multidimensional health benefits
    • Rapamycin: The Anti-Aging Wonder Drug
  • Rhesus Negative
  • Self Employed Health Insurance
  • Semaglutide: A Safe and Effective Alternative to Surgical Weight Loss
    • Semaglutide and its Weight Loss Benefits
    • Semaglutide: A Revolutionary Treatment Explored
    • Semaglutide: Bridging Diabetes Treatment and Weight Loss While Managing Side Effects
    • Semaglutide: Revolutionizing Weight Loss and Diabetes Management
    • Semaglutide: Transforming Weight Management and Glycemic Control
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • Terms of Use
  • Testosterone Replacement Therapy Insights
    • Exploring the HCG Diet: Unveiling a Unique Pathway Towards Weight Management
    • Testosterone for Females: Balancing Health & Wellness
      • Testosterone for Females: Exploration of Hormonal Balance and Health
    • Testosterone Replacement Therapy (TRT): A Comprehensive Guide
    • Unlocking the Pivotal Role of Testosterone in Holistic Wellbeing
  • Testosterone Therapy: Weighing the Benefits, Risks, and Identifying Symptoms
    • The Vital Role of Testosterone in Health & Well-being
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Marvels and Misgivings of Rapamycin: A Glimpse into Anti-aging and Longevity Benefits
  • The Use of Post Cycle Therapy Supplements
  • Timeless Beauty Med Spa: Elevating Skincare in Dallas, Texas
    • Achieve Your Body Goals with Emsculpt Neo: Now Available at Timeless Beauty Med Spa in Dallas, Texas
    • The Ultimate Guide to Facials: A Path to Radiant Skin
  • Travel Health Insurance
  • Ultimate Guide for Anavar Cycles
  • Understanding Metformin: Benefits and Insights
    • Metformin: A Pillar of Hope in Weight Loss Journeys
    • Metformin: The Multifaceted Medication for Modern Health Challenges
  • Understanding Nandrolone: Benefits and Uses
    • Demystifying Nandrolone: Uses, Potential Benefits, and Considerations
    • Nandrolone for Joint Pain: Efficacy, Benefits, and Considerations
    • Nandrolone: From Muscle Building to Therapeutic Uses and Side Effects
  • Unleash your Potential with Nandrolone & Deca Durabolin
  • Unleashing Glutathione’s Power: The Key to Anti-Aging and Health
  • Unlocking Testosterone’s Power: A Comprehensive Guide to Better Health
  • Winstrol – Beyond the World of Bodybuilding
    • Unlocking the Potential of Winstrol: Dosage, Benefits, and Risks

Copyright © 2025 - Privacy Policy - Terms of Use - Disclaimer